Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7255 results

Sort By:

International Ovarian & Testicular Stromal Tumor Registry

Study ID: NCT01970696
Start Date: 2011-12-08
End Date: 2030-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment
Sponsor

Children's Hospitals and Clinics of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

Study ID: NCT06225596
Start Date: 2024-01-24
End Date: 2030-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

956

Intervention / Treatment

BT8009

BT8009

BT8009

Pembrolizumab

Gemcitabine + cisplatin Or carboplatin

Avelumab

Sponsor

BicycleTx Limited

Source: clinicaltrials.gov

Share:
Add to list

Relationships Between Physical Activity and Different Measures of Fatigue in Cancer Survivors

Study ID: NCT05073848
Start Date: 2021-10-20
End Date: 2026-06-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment
Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Study ID: NCT05136196
Start Date: 2022-12-06
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

150

Intervention / Treatment

Biopsy Procedure

Biospecimen Collection

Cabozantinib S-malate

Computed Tomography

Magnetic Resonance Imaging

Nivolumab

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

OHSV2-PD-L1/CD3-BsAb Administered Via Intratumoral Injection

Study ID: NCT05938296
Start Date: 2023-12-19
End Date: 2026-01-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

29

Intervention / Treatment

BS006 Injection

Sponsor

Binhui Biopharmaceutical Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Stage II/III Colorectal Cancer Recurrence

Study ID: NCT06314958
Start Date: 2023-03-15
End Date: 2026-06-18
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

CENSURE

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active

Study ID: NCT06649058
Start Date: 2025-02-14
End Date: 2030-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

316

Intervention / Treatment

Systemic Therapy

Stereotactic Radiosurgery

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer

Study ID: NCT06315296
Start Date: 2023-12-13
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Behavioral Dietary Intervention

Text Message-Based Navigation Intervention

Internet-Based Intervention

Dietary Counseling and Surveillance

Stereotactic Radiosurgery

Biospecimen Collection

Magnetic Resonance Imaging

Neurocognitive Assessment

Administration questionnaire

Interview

Internet-Based Intervention

Stereotactic Radiosurgery

Text Message-Based Navigation Intervention

Biospecimen Collection

Magnetic Resonance Imaging

Neurocognitive Assessment

Administration questionnaire

Interview

Sponsor

Thomas Jefferson University

Source: clinicaltrials.gov

Share:
Add to list

Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-

Study ID: NCT06937996
Start Date: 2025-05-13
End Date: 2035-05-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

NanoKnife

Sponsor

Englewood Hospital and Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors

Study ID: NCT04479696
Start Date: 2019-06-05
End Date: 2027-02-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

117

Intervention / Treatment

Educational Intervention

Administration questionnaire

Survey Administration

Video

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list